Nevanac label

Nevanac

Nevanac Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

NEVANAC® ophthalmic suspension is indicated for the treatment of pain and inflammation associated with cataract surgery.

History

There is currently no drug history available for this drug.

Other Information

NEVANAC® (nepafenac ophthalmic suspension) 0.1% is a sterile, topical, nonsteroidal anti-inflammatory (NSAID) prodrug for ophthalmic use. Each mL of NEVANAC® suspension contains 1 mg of nepafenac. Nepafenac is designated chemically as 2-amino-3-benzoylbenzeneacetamide with an empirical formula of C15H14N2O2. The structural formula of nepafenac is:

Image from Drug Label Content

Nepafenac is a yellow crystalline powder. The molecular weight of nepafenac is 254.28. NEVANAC® ophthalmic suspension is supplied as a sterile, aqueous 0.1% suspension with a pH approximately of 7.4.

The osmolality of NEVANAC® ophthalmic suspension is approximately 305 mOsmol/kg.

Each mL of NEVANAC® contains: Active: nepafenac 0.1% Inactives: mannitol, carbomer 974P, sodium chloride, tyloxapol, edetate disodium, benzalkonium chloride 0.005% (preservative), sodium hydroxide and/or hydrochloric acid to adjust pH and purified water, USP.

Nevanac Manufacturers

  • Nevanac | Alcon Laboratories, Inc.
    No Recall

    Nevanac | Alcon Laboratories, Inc.

    Nevanac | Alcon Laboratories, Inc.
    2.1 Recommended Dosing

    One drop of NEVANAC should be applied to the affected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.

    2.2 Use with Other Topical Ophthalmic Medications

    NEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.

  • Physicians Total Care, Inc.
    Nevanac | Physicians Total Care, Inc.
    No Recall

    Nevanac | Physicians Total Care, Inc.

    Nevanac | Physicians Total Care, Inc.

    Enter section text here

    2.1 Recommended Dosing

    One drop of NEVANAC® should be applied to the affected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.

    2.2 Use with Other Topical Ophthalmic Medications

    NEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.

  • Nevanac | Alcon Laboratories, Inc.
    No Recall

    Nevanac | Alcon Laboratories, Inc.

    Nevanac | Alcon Laboratories, Inc.
    2.1 Recommended Dosing

    One drop of NEVANAC® should be applied to the affected eye three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.

    2.2 Use with Other Topical Ophthalmic Medications

    NEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.

    If more than one topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.